Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study”

Ennio Giulio Favalli, Fabrizio Conti, Fabiola Atzeni, Carlo Selmi, Salvatore D'Angelo, Roberto Caporali, Florenzo Iannone

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e119-e120
JournalJournal of the American Academy of Dermatology
Volume79
Issue number6
DOIs
Publication statusPublished - Dec 1 2018

ASJC Scopus subject areas

  • Dermatology

Cite this